Expanding AI Capabilities patientMpower is actively developing AI-powered tools for predicting lung disease, indicating opportunities to collaborate with healthcare providers seeking advanced predictive analytics and personalized care solutions.

Strong Global Presence With implementations in the US, UK, and Ireland, patientMpower serves a broad international market, opening doors for partners interested in scalable remote monitoring solutions across different healthcare systems.

Innovative Research Initiatives Recent projects like monitoring rural interstitial lung disease and participation in the open-source OPUS project demonstrate a commitment to research and innovation, creating opportunities to partner with research institutions or funding bodies.

Digital Care Integration Through its platform enabling data collection via connected devices and integration with electronic medical records, patientMpower appeals to healthcare providers looking for seamless telehealth solutions to enhance patient management.

Funding and Growth Potential With recent funding of $2.3 million and a focus on expanding AI and feature development, there are sales prospects in offering advanced digital health tools, platform expansion services, or strategic investments for scaling operations.